# Full texts needed for the next teaching pass

Reviewed 2 October 2026. These are specific acquisition requests, not a request
for another broad literature collection. Existing source PDFs are not redistributed.

| Priority | Article and requested material | What it would unlock | Access in this run |
|---|---|---|---|
| High | **Seguin et al. 2026**, *White matter pathways mediating dorsolateral prefrontal TMS therapy for depression*. DOI [10.1038/s41593-026-02248-6](https://www.nature.com/articles/s41593-026-02248-6). Published full text and Supplementary Information. | Review the intermediate regions, route definitions and qualifications before adding a structural, multi-step DLPFC–sgACC teaching schematic. | Publisher abstract and data/code statements accessible; full text is subscription content. An exact-title search did not locate a verified public full manuscript. The previously audited public code/data repository does not replace the full methods. No new route topology was added. |
| Medium | **Machado et al. 2009**, *Functional topography of the ventral striatum and anterior limb of the internal capsule determined by electrical stimulation of awake patients*. DOI [10.1016/j.clinph.2009.05.030](https://pubmed.ncbi.nlm.nih.gov/19781987/). Full text, figures/tables and any supplements. | Extend the contact comparison to a depression cohort and review the spatial mapping of acute effects. | PubMed abstract accessible; ScienceDirect returned 403. Exact-title and author/PDF searches did not locate a verified public full manuscript. No contact-level claim from this paper was incorporated. |

## Public material obtained without a user request

- **Tsai 2014**, DOI 10.2147/NDT.S54964: public full text via Europe PMC XML,
  including Methods, Results, Table 2 and Discussion. Supplies the published
  contact comparison. The article describes 0–3 numbering, 1.5-mm contacts,
  1.5-mm gaps and a 1.27-mm lead diameter.
- **Tyagi 2019**, DOI 10.1016/j.biopsych.2019.01.017: public full text via PMC
  and Europe PMC XML. Relevant methods, contact-location results, tractography
  and target comparisons rechecked. The main article supports the selected
  teaching claims; individual patient streamlines/registration data remain absent.
- **Ji 2021**, PMID 34050701: public full text via Europe PMC XML. Right pre-SMA
  targeting, STN functional connectivity, sample, clinical result and limitations
  reviewed. This supplies a distinct pre-SMA lesson.
- **Fridgeirsson 2020**, DOI 10.1093/brain/awaa100: public full text obtained and
  reviewed for a possible subsequent affective-network lesson. It is not a new
  lesson or a contact-specific explanation in this release. No need to retrieve it.
- **Device dimensions**: public FDA SSED P150031/S028, printed page 22, checked
  against Tsai's methods. Used only to confirm hardware dimensions; no regulatory
  indication or programming recommendation is inferred from that document.

Other teaching claims reuse the atlas's reviewed evidence records. Their earlier
review scope is retained in the lesson sources. Holtzheimer's controlled result
uses the already reviewed published abstract; no additional full-text-only
claims were required for this release.

## Gaps that a full-text PDF will not necessarily solve

The current contact comparison has a dimensioned **lead**, not a lead registered
to a patient's anatomy. A validated millimeter-level pathway view needs a matched
lead reconstruction, MRI and tract geometry in one coordinate space, alignment
quality checks and, if activation is depicted, appropriate stimulation parameters
and modeling. Public article images or contact numbers alone do not supply this.

The current cross-template population atlas is not used to assign a specific tract
to Tsai's contact responses. Tyagi's group network results are a separate example.

Next week's highest-value clinical input is Figee's sketch or a brief account naming
the deep target, cortical destinations and connections he was explaining, plus
which lead/contact example he meant. The teaching draft does not claim his review.
